DOI: 10.21276/ajptr
Tue, 21 May 2019

Design and In-Vitro evaluation of human serum albumin loaded Paclitaxel nanosuspension


AmarnathReddy Ganji1,*, Kiran K Jadhav1, Sanjay P Umachigi1, Pradeep Shivakumar1, Palleti SainathReddy1, Yedla Anilchowdary2


1. Gautham College of Pharmacy, Department of Pharmaceutics, Bangalore, India.

2. Lamar University, Department of Chemistry, Beaumont, Texas, U.S.A.



At current 40% of the drugs were poorly soluble and were also called as “brick dust”. And the drugs which were belonging to the BCS CLASS II & IV were most eligible for this Nanosuspension technology. Here by using different methods we are reducing the particle size so the surface area will be increases ultimately it leads to increase in the bio availability. This instance was observed mostly in the case of anti-cancer drugs. Paclitaxel with 25% of Human Serum Albumin (HSA) showed very good results in terms of drug content, particle size, zeta potential and %CDR.

Key words: Nanosuspension, Paclitaxel, Human Serum Albumin (HSA), High pressure homogenization.

[PDF]   Viewed: 1976   Downloaded: 222
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter